Cited by 85Bipolar Disorder and TreatmentTreatment of Major DepressionNeuroscience and Neuropharmacology Research

Role of Protein Kinase C in Bipolar Disorder: A Review of the Current Literature

Open access
Saxena, Ashwini, Scaini, Giselli, Bavaresco, Daniela V., Leite, Camila, Valvassoria, Samira S., Carvalho, André F., Quevedo, João·2017·Complex Psychiatry

Abstract

Bipolar disorder (BD) is a major health problem. It causes significant morbidity and imposes a burden on the society. Available treatments help a substantial proportion of patients but are not beneficial for an estimated 40-50%. Thus, there is a great need to further our understanding the pathophysiology of BD to identify new therapeutic avenues. The preponderance of evidence pointed towards a role of protein kinase C (PKC) in BD. We reviewed the literature pertinent to the role of PKC in BD. We present recent advances from preclinical and clinical studies that further support the role of PKC. Moreover, we discuss the role of PKC on synaptogenesis and neuroplasticity in the context of BD. The recent development of animal models of BD, such as stimulant-treated and paradoxical sleep deprivation, and the ability to intervene pharmacologically provide further insights into the involvement of PKC in BD. In addition, the effect of PKC inhibitors, such as tamoxifen, in the resolution of manic symptoms in patients with BD further points in that direction. Furthermore, a wide variety of growth factors influence neurotransmission through several molecular pathways that involve downstream effects of PKC. Our current understanding identifies the PKC pathway as a potential therapeutic avenue for BD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000480349

Cites

179 of 179 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Based on these studies and human clinical data, the pathophysiology of environmental circadian disruption underlying bipolar mania may be via altered protein kinase C activity affecting neuronal signaling in frontal and limbic brain regions.

    “Based on these studies and human clinical data, the pathophysiology of environmental circadian disruption underlying bipolar mania may be via altered protein kinase c activity affecting neuronal signaling in frontal and limbic brain regions139.”

    From Circadian rhythm disruption and mental health (2020) · cites this paper as [139]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 12

  1. Grande I, Berk M, Birmaher B, Vieta E: Bipo- lar disorder. Lancet 2016; 387: 1561-1572.
  2. Sharma AN, Fries GR, Galvez JF, Valvassori SS, Soares JC, Carvalho AF, Quevedo J: Mod- eling mania in preclinical settings: a compre- hensive review. Prog Neuropsychopharmacol Biol Psychiatry 2016; 66: 22-34.
  3. Talaei A, Pourgholami M, Khatibi-Moghad- am H, Faridhosseini F, Farhoudi F, Askari- Noghani A, Sadeghi R: Tamoxifen: a protein kinase C inhibitor to treat mania: a system- atic review and meta-analysis of randomized, placebo-controlled trials. J Clin Psychophar- macol 2016; 36: 272-275.
  4. Ohno S, Nishizuka Y: Protein kinase C iso- types and their specific functions: prologue. J Biochem 2002; 132: 509-511.
  5. Naik MU, Benedikz E, Hernandez I, Libien J, Hrabe J, Valsamis M, Dow-Edwards D, Os- man M, Sacktor TC: Distribution of protein kinase Mzeta and the complete protein kinase C isoform family in rat brain. J Comp Neurol 2000; 426: 243-258.
  6. Hadley SH, Bahia PK, Taylor-Clark TE: Sen- sory nerve terminal mitochondrial dysfunc- tion induces hyperexcitability in airway noci- ceptors via protein kinase C. Mol Pharmacol 2014; 85: 839-848.
  7. Soares JC, Mallinger AG: Intracellular phos- phatidylinositol pathway abnormalities in bi- polar disorder patients. Psychopharmacol Bull 1997; 33: 685-691.
  8. Sharkey NA, Leach KL, Blumberg PM: Com- petitive inhibition by diacylglycerol of specif- ic phorbol ester binding. Proc Natl Acad Sci USA 1984; 81: 607-610.
  9. Dager SR, Friedman SD, Parow A, Demopu- los C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF: Brain metabolic alterations in medica- tion-free patients with bipolar disorder. Arch Gen Psychiatry 2004; 61: 450-458.
  10. Broadbelt K, Ramprasaud A, Jones LB: Evi- dence of altered neurogranin immunoreac- tivity in areas 9 and 32 of schizophrenic pre- frontal cortex. Schizophr Res 2006; 87: 6-14.
  11. Shimazaki Y, Nishiki T, Omori A, Sekiguchi M, Kamata Y, Kozaki S, Takahashi M: Phos- phorylation of 25-kDa synaptosome-associ- ated protein. Possible involvement in pro- tein kinase C-mediated regulation of neu- rotransmitter release. J Biol Chem 1996; 271: 14548-14553. 120
  12. Sakane F, Kanoh H: Molecules in focus: dia- cylglycerol kinase. Int J Biochem Cell Biol 1997; 29: 1139-1143. 158

Cited by

Sorted by citations

Authors
Saxena, A., Scaini, G., Bavaresco, D. V., Leite, C., Valvassoria, S. S., Carvalho, A. F., & Quevedo, J.
Affiliations
  • The University of Texas Health Science Center at Houston (US)
  • The University of Texas System (US)
Venue
Complex Psychiatry
Publisher
S. Karger AG
Published
2017
Volume
3
Issue
2
Pages
108-124
ISSN
  • 2673-298X (ISSN-L)
  • 2673-3005
OpenAlex
W2763250674
Cited by
85
References
179
Citations by year
2026: 4 · 2025: 5 · 2024: 7 · 2023: 6 · 2022: 13 · 2021: 24 · 2020: 14 · 2019: 7 · 2018: 4
FWCI
1.04
Type
journal article
Language
en
Open access
Locations
  • Complex Psychiatry (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina
  • Universidade do Extremo Sul Catarinense
  • Instituto Mente e Cérebro - Neurociência
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
protein kinase C, bipolar disorder, pathophysiology, synaptogenesis, neuroplasticity, REM sleep deprivation, tamoxifen, PKC inhibitors, growth factors, neurotransmission, manic symptoms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review